Stock Analysis on Net
Stock Analysis on Net

Allergan Inc. (NYSE:AGN.)

This company has been moved to the archive! The financial data has not been updated since February 19, 2015.

DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
Quarterly Data

Microsoft Excel

Decomposing ROE involves expressing net income divided by shareholders’ equity as the product of component ratios.

Two-Component Disaggregation of ROE

Allergan Inc., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = ROA × Financial Leverage
Dec 31, 2014 19.66% = 12.28% × 1.60
Sep 30, 2014 18.28% = 11.16% × 1.64
Jun 30, 2014 18.97% = 11.71% × 1.62
Mar 31, 2014 18.58% = 11.47% × 1.62
Dec 31, 2013 15.24% = 9.32% × 1.64
Sep 30, 2013 16.37% = 9.82% × 1.67
Jun 30, 2013 16.53% = 9.78% × 1.69
Mar 31, 2013 16.52% = 9.53% × 1.73
Dec 31, 2012 18.82% = 11.97% × 1.57
Sep 30, 2012 18.93% = 11.83% × 1.60
Jun 30, 2012 19.39% = 12.16% × 1.59
Mar 31, 2012 18.43% = 11.58% × 1.59
Dec 31, 2011 17.60% = 10.98% × 1.60
Sep 30, 2011 17.98% = 11.21% × 1.60
Jun 30, 2011 -0.05% = -0.03% × 1.59
Mar 31, 2011 -0.18% = -0.11% × 1.72
Dec 31, 2010 0.01% = 0.01% × 1.75
Sep 30, 2010 — = — × 1.92
Jun 30, 2010 — = — × 1.53
Mar 31, 2010 — = — × 1.54

Based on: 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31), 10-K (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-Q (reporting date: 2011-03-31), 10-K (reporting date: 2010-12-31), 10-Q (reporting date: 2010-09-30), 10-Q (reporting date: 2010-06-30), 10-Q (reporting date: 2010-03-31).

The primary reason for the increase in return on equity ratio (ROE) over Q4 2014 is the increase in profitability measured by return on assets ratio (ROA).

Three-Component Disaggregation of ROE

Allergan Inc., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = Net Profit Margin × Asset Turnover × Financial Leverage
Dec 31, 2014 19.66% = 21.39% × 0.57 × 1.60
Sep 30, 2014 18.28% = 18.85% × 0.59 × 1.64
Jun 30, 2014 18.97% = 19.40% × 0.60 × 1.62
Mar 31, 2014 18.58% = 19.27% × 0.60 × 1.62
Dec 31, 2013 15.24% = 15.90% × 0.59 × 1.64
Sep 30, 2013 16.37% = 16.54% × 0.59 × 1.67
Jun 30, 2013 16.53% = 16.07% × 0.61 × 1.69
Mar 31, 2013 16.52% = 15.26% × 0.62 × 1.73
Dec 31, 2012 18.82% = 19.25% × 0.62 × 1.57
Sep 30, 2012 18.93% = 18.81% × 0.63 × 1.60
Jun 30, 2012 19.39% = 19.08% × 0.64 × 1.59
Mar 31, 2012 18.43% = 18.42% × 0.63 × 1.59
Dec 31, 2011 17.60% = 17.48% × 0.63 × 1.60
Sep 30, 2011 17.98% = 17.47% × 0.64 × 1.60
Jun 30, 2011 -0.05% = -0.05% × 0.65 × 1.59
Mar 31, 2011 -0.18% = -0.18% × 0.59 × 1.72
Dec 31, 2010 0.01% = 0.01% × 0.58 × 1.75
Sep 30, 2010 — = — × — × 1.92
Jun 30, 2010 — = — × — × 1.53
Mar 31, 2010 — = — × — × 1.54

Based on: 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31), 10-K (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-Q (reporting date: 2011-03-31), 10-K (reporting date: 2010-12-31), 10-Q (reporting date: 2010-09-30), 10-Q (reporting date: 2010-06-30), 10-Q (reporting date: 2010-03-31).

The primary reason for the increase in return on equity ratio (ROE) over Q4 2014 is the increase in profitability measured by net profit margin ratio.

Five-Component Disaggregation of ROE

Allergan Inc., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Financial Leverage
Dec 31, 2014 19.66% = 0.77 × 0.97 × 28.77% × 0.57 × 1.60
Sep 30, 2014 18.28% = 0.72 × 0.96 × 27.05% × 0.59 × 1.64
Jun 30, 2014 18.97% = 0.72 × 0.96 × 28.21% × 0.60 × 1.62
Mar 31, 2014 18.58% = 0.72 × 0.96 × 28.05% × 0.60 × 1.62
Dec 31, 2013 15.24% = 0.68 × 0.95 × 24.50% × 0.59 × 1.64
Sep 30, 2013 16.37% = 0.69 × 0.95 × 25.27% × 0.59 × 1.67
Jun 30, 2013 16.53% = 0.70 × 0.95 × 24.20% × 0.61 × 1.69
Mar 31, 2013 16.52% = 0.68 × 0.95 × 23.49% × 0.62 × 1.73
Dec 31, 2012 18.82% = 0.72 × 0.96 × 27.91% × 0.62 × 1.57
Sep 30, 2012 18.93% = 0.72 × 0.96 × 27.30% × 0.63 × 1.60
Jun 30, 2012 19.39% = 0.71 × 0.96 × 28.15% × 0.64 × 1.59
Mar 31, 2012 18.43% = 0.72 × 0.96 × 26.90% × 0.63 × 1.59
Dec 31, 2011 17.60% = 0.72 × 0.95 × 25.58% × 0.63 × 1.60
Sep 30, 2011 17.98% = 0.74 × 0.94 × 25.28% × 0.64 × 1.60
Jun 30, 2011 -0.05% = -0.02 × 0.65 × 4.84% × 0.65 × 1.59
Mar 31, 2011 -0.18% = -0.06 × 0.63 × 4.77% × 0.59 × 1.72
Dec 31, 2010 0.01% = 0.00 × 0.68 × 5.09% × 0.58 × 1.75
Sep 30, 2010 — = — × — × — × — × 1.92
Jun 30, 2010 — = — × — × — × — × 1.53
Mar 31, 2010 — = — × — × — × — × 1.54

Based on: 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31), 10-K (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-Q (reporting date: 2011-03-31), 10-K (reporting date: 2010-12-31), 10-Q (reporting date: 2010-09-30), 10-Q (reporting date: 2010-06-30), 10-Q (reporting date: 2010-03-31).

The primary reason for the increase in return on equity ratio (ROE) over Q4 2014 is the increase in operating profitability measured by EBIT margin ratio.

Two-Component Disaggregation of ROA

Allergan Inc., decomposition of ROA (quarterly data)

Microsoft Excel
ROA = Net Profit Margin × Asset Turnover
Dec 31, 2014 12.28% = 21.39% × 0.57
Sep 30, 2014 11.16% = 18.85% × 0.59
Jun 30, 2014 11.71% = 19.40% × 0.60
Mar 31, 2014 11.47% = 19.27% × 0.60
Dec 31, 2013 9.32% = 15.90% × 0.59
Sep 30, 2013 9.82% = 16.54% × 0.59
Jun 30, 2013 9.78% = 16.07% × 0.61
Mar 31, 2013 9.53% = 15.26% × 0.62
Dec 31, 2012 11.97% = 19.25% × 0.62
Sep 30, 2012 11.83% = 18.81% × 0.63
Jun 30, 2012 12.16% = 19.08% × 0.64
Mar 31, 2012 11.58% = 18.42% × 0.63
Dec 31, 2011 10.98% = 17.48% × 0.63
Sep 30, 2011 11.21% = 17.47% × 0.64
Jun 30, 2011 -0.03% = -0.05% × 0.65
Mar 31, 2011 -0.11% = -0.18% × 0.59
Dec 31, 2010 0.01% = 0.01% × 0.58
Sep 30, 2010 — = — × —
Jun 30, 2010 — = — × —
Mar 31, 2010 — = — × —

Based on: 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31), 10-K (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-Q (reporting date: 2011-03-31), 10-K (reporting date: 2010-12-31), 10-Q (reporting date: 2010-09-30), 10-Q (reporting date: 2010-06-30), 10-Q (reporting date: 2010-03-31).

The primary reason for the increase in return on assets ratio (ROA) over Q4 2014 is the increase in profitability measured by net profit margin ratio.

Four-Component Disaggregation of ROA

Allergan Inc., decomposition of ROA (quarterly data)

Microsoft Excel
ROA = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover
Dec 31, 2014 12.28% = 0.77 × 0.97 × 28.77% × 0.57
Sep 30, 2014 11.16% = 0.72 × 0.96 × 27.05% × 0.59
Jun 30, 2014 11.71% = 0.72 × 0.96 × 28.21% × 0.60
Mar 31, 2014 11.47% = 0.72 × 0.96 × 28.05% × 0.60
Dec 31, 2013 9.32% = 0.68 × 0.95 × 24.50% × 0.59
Sep 30, 2013 9.82% = 0.69 × 0.95 × 25.27% × 0.59
Jun 30, 2013 9.78% = 0.70 × 0.95 × 24.20% × 0.61
Mar 31, 2013 9.53% = 0.68 × 0.95 × 23.49% × 0.62
Dec 31, 2012 11.97% = 0.72 × 0.96 × 27.91% × 0.62
Sep 30, 2012 11.83% = 0.72 × 0.96 × 27.30% × 0.63
Jun 30, 2012 12.16% = 0.71 × 0.96 × 28.15% × 0.64
Mar 31, 2012 11.58% = 0.72 × 0.96 × 26.90% × 0.63
Dec 31, 2011 10.98% = 0.72 × 0.95 × 25.58% × 0.63
Sep 30, 2011 11.21% = 0.74 × 0.94 × 25.28% × 0.64
Jun 30, 2011 -0.03% = -0.02 × 0.65 × 4.84% × 0.65
Mar 31, 2011 -0.11% = -0.06 × 0.63 × 4.77% × 0.59
Dec 31, 2010 0.01% = 0.00 × 0.68 × 5.09% × 0.58
Sep 30, 2010 — = — × — × — × —
Jun 30, 2010 — = — × — × — × —
Mar 31, 2010 — = — × — × — × —

Based on: 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31), 10-K (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-Q (reporting date: 2011-03-31), 10-K (reporting date: 2010-12-31), 10-Q (reporting date: 2010-09-30), 10-Q (reporting date: 2010-06-30), 10-Q (reporting date: 2010-03-31).

The primary reason for the increase in return on assets ratio (ROA) over Q4 2014 is the increase in operating profitability measured by EBIT margin ratio.

Disaggregation of Net Profit Margin

Allergan Inc., decomposition of net profit margin ratio (quarterly data)

Microsoft Excel
Net Profit Margin = Tax Burden × Interest Burden × EBIT Margin
Dec 31, 2014 21.39% = 0.77 × 0.97 × 28.77%
Sep 30, 2014 18.85% = 0.72 × 0.96 × 27.05%
Jun 30, 2014 19.40% = 0.72 × 0.96 × 28.21%
Mar 31, 2014 19.27% = 0.72 × 0.96 × 28.05%
Dec 31, 2013 15.90% = 0.68 × 0.95 × 24.50%
Sep 30, 2013 16.54% = 0.69 × 0.95 × 25.27%
Jun 30, 2013 16.07% = 0.70 × 0.95 × 24.20%
Mar 31, 2013 15.26% = 0.68 × 0.95 × 23.49%
Dec 31, 2012 19.25% = 0.72 × 0.96 × 27.91%
Sep 30, 2012 18.81% = 0.72 × 0.96 × 27.30%
Jun 30, 2012 19.08% = 0.71 × 0.96 × 28.15%
Mar 31, 2012 18.42% = 0.72 × 0.96 × 26.90%
Dec 31, 2011 17.48% = 0.72 × 0.95 × 25.58%
Sep 30, 2011 17.47% = 0.74 × 0.94 × 25.28%
Jun 30, 2011 -0.05% = -0.02 × 0.65 × 4.84%
Mar 31, 2011 -0.18% = -0.06 × 0.63 × 4.77%
Dec 31, 2010 0.01% = 0.00 × 0.68 × 5.09%
Sep 30, 2010 — = — × — × —
Jun 30, 2010 — = — × — × —
Mar 31, 2010 — = — × — × —

Based on: 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31), 10-K (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-Q (reporting date: 2011-03-31), 10-K (reporting date: 2010-12-31), 10-Q (reporting date: 2010-09-30), 10-Q (reporting date: 2010-06-30), 10-Q (reporting date: 2010-03-31).

The primary reason for the increase in net profit margin ratio over Q4 2014 is the increase in operating profitability measured by EBIT margin ratio.